about
Neglected infections of poverty in the United States of AmericaA research agenda for helminth diseases of humans: intervention for control and eliminationNeglected Tropical Diseases in the Anthropocene: The Cases of Zika, Ebola, and Other InfectionsHelminth infections: the great neglected tropical diseasesA research agenda for helminth diseases of humans: basic research and enabling technologies to support control and elimination of helminthiasesHelminth elimination in the pursuit of sustainable development goals: a "worm index" for human development"Vaccine diplomacy": historical perspectives and future directionsTexas and Mexico: sharing a legacy of poverty and neglected tropical diseasesNeglected tropical disease control in the "post-American world"Nuclear weapons and neglected diseases: the "ten-thousand-to-one gap"The cross-cutting contribution of the end of neglected tropical diseases to the sustainable development goalsPlant-made vaccines in support of the Millennium Development Goals.Vaccines to combat the neglected tropical diseases.Analysis of Schistosoma mansoni genes shared with Deuterostomia and with possible roles in host interactions.Ivermectin resistance in Onchocerca volvulus: toward a genetic basisThe neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination.A constitutional amendment for dewormingDifferential expression of anti-glycan antibodies in schistosome-infected humans, rhesus monkeys and miceQuantifying the burden of rhodesiense sleeping sickness in Urambo District, TanzaniaMolecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus.New antipoverty drugs, vaccines, and diagnostics: a research agenda for the US President's Global Health Initiative (GHI).A new approach to characterize populations of Schistosoma mansoni from humans: development and assessment of microsatellite analysis of pooled miracidia.Social sciences research in neglected tropical diseases 1: the ongoing neglect in the neglected tropical diseases.Active surveillance of Hansen's Disease (leprosy): importance for case finding among extra-domiciliary contacts.Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate modelsModel for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm.Subunit approach to evaluation of the immune protective potential of leptospiral antigensThe economic value of a visceral leishmaniasis vaccine in Bihar state, India.Schistosomes Enhance Plasminogen Activation: The Role of Tegumental EnolaseAntigen targeting to major histocompatibility complex class II with streptococcal mitogenic exotoxin Z-2 M1, a superantigen-based vaccine carrierDengue Vaccines: A Perspective from the Point of View of Intellectual Property.The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis.Vaccines against tropical parasitic diseases: a persisting answer to a persisting problemMultivalent anthelminthic vaccine to prevent hookworm and schistosomiasis.Helminth infections and intestinal inflammationHuman leukocyte antigen (HLA)-B, DRB1, and DQB1 allotypes associated with disease and protection of trachoma endemic villagers.Neglected tropical diseases in Brazil.Potency testing for the experimental Na-GST-1 hookworm vaccine.The Impact of Nurses on Neglected Tropical Disease Management.Targeting Dendritic Cells as a Good Alternative to Combat Leishmania spp.
P2860
Q21144547-EAE572F4-DB52-4732-86EC-04922AAF122FQ21562256-4CCD0094-6C0C-48B5-8199-8BF54517CAA7Q24261182-3f7b0b34-4840-e508-4beb-9b2da145dc6eQ24648324-B81D348E-762A-47B8-9315-584A9732157DQ28482492-F168A906-300B-4E41-8221-C0F6CDBE3B80Q28648184-CB44AF17-533E-425A-918E-153A95648CBBQ28657435-5BC4D5D9-4BE7-42F3-A416-BBF2733DD3E7Q28730915-2C9FE879-8CC6-4E09-B387-4A4EAC085D2EQ28749509-BC079F8E-B9C0-430B-B1F0-B9A7D75841F5Q28752414-B599026D-25FD-4620-AEEB-272CD945D3ECQ30061753-9A153B56-08F7-4EE6-BA3A-838418CE4E06Q30396217-04060F83-85D4-4A92-8472-9D3C607D244CQ30425005-9541EBE5-22A9-4653-8F08-84264D206580Q30837224-2162BB78-95B9-4A5C-ACEC-10BBF4DEA630Q33305360-47B58731-4AC2-4442-B703-F6E9414A2299Q33372349-0BAAE6FC-F64F-4063-B35B-A93389370C39Q33496752-93441BCE-4E90-4C89-9CBD-EEE701365547Q33684613-CF8883F4-C635-47A6-AFF8-85D080ADB85DQ33745212-00E54792-238A-4256-8D87-57C69EB447F5Q33769088-1666B62E-F26E-49E8-AE74-207E10A85839Q33927439-F7EAFC95-7CD9-46D8-9D2D-ECC8CEB68722Q33941754-D5E3BF50-7B1A-4881-9F4B-DFF84058F43CQ34331546-7371AA6F-6ECD-4A3E-B7AC-214C658EA358Q34630504-D6750AB1-8651-4EEF-B2D9-CF62F248B070Q34713889-27017D58-B3AD-4096-AAF8-2C74DFFCA53EQ34893725-B6B0E800-C0A5-4AC3-A35A-707610460263Q35598213-0EAB9434-D4CD-436B-AFFC-A396614918DFQ35771782-62FBAF91-4BF3-4348-A282-F9197BA8F589Q35867049-ABBB2D89-A735-4F4B-B3DF-E4CAD65C920FQ35867230-658FA725-C265-4BE0-8128-C949F24EDF62Q36012898-B0377E10-0B9C-4D25-8681-A2FB52B5AC17Q36013519-6348EBC0-8449-4AF0-BF80-62866F0EC6B8Q36748445-C215B584-C7E7-43FA-8AB7-FEF503E66FC0Q37229920-096DA9DC-85A7-438D-AA1D-C1E1E8474E9BQ37262993-6085A5CD-3F2F-4CDA-8C8A-CB426B40B2E7Q37368025-DA401C3F-9F89-4B2F-93D4-A7C5468B2A1AQ37628525-7AE5778C-0E96-4EDD-B155-C3D6B44FD7CAQ37798012-B6FBDE76-1836-4321-8498-53422070B0DAQ38250382-CED369CC-82F0-4AFC-9C9F-16D829DE00CAQ38287969-75EA8E04-6F72-4D74-AF39-65078932D168
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The antipoverty vaccines
@ast
The antipoverty vaccines
@en
The antipoverty vaccines
@en-gb
The antipoverty vaccines
@nl
type
label
The antipoverty vaccines
@ast
The antipoverty vaccines
@en
The antipoverty vaccines
@en-gb
The antipoverty vaccines
@nl
prefLabel
The antipoverty vaccines
@ast
The antipoverty vaccines
@en
The antipoverty vaccines
@en-gb
The antipoverty vaccines
@nl
P3181
P1433
P1476
The antipoverty vaccines
@en
P2093
Meghan T Ferris
P304
P3181
P356
10.1016/J.VACCINE.2006.05.008
P407
P577
2006-07-26T00:00:00Z